Healthcare Providers and Services
Company Overview of Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center is engaged in the research to prevent, detect, and treat cancer, HIV/AIDS, and other life-threatening diseases. Its activities in the areas of diseases and research cover fundamental research, prevention, early detection, treatment and cures, and survivorship. The company was incorporated in 1971 and is based in Seattle, Washington.
1100 Fairview Avenue North
P.O. Box 19024
Seattle, WA 98109-1024
Founded in 1971
Key Executives for Fred Hutchinson Cancer Research Center
President and Director of Vaccine & Infectious Disease Division
Chief Financial Officer and Vice President
Chief Operating Officer and Executive Vice President
Chief Information Officer and Vice President
Vice President and General Counsel
Compensation as of Fiscal Year 2013.
Fred Hutchinson Cancer Research Center Key Developments
Fred Hutchinson Cancer Research Center Appoints Gary Lyman as Co-Director of the Hutchinson Institute for Cancer Outcomes Research
Jan 27 14
Dr. Gary Lyman was appointed co-director of the Hutchinson Institute for Cancer Outcomes Research at Fred Hutchinson Cancer Research Center in Seattle. Lyman had served as professor of medicine and senior fellow at the Duke Center for Clinical Health Policy Research and also director of the Comparative Effectiveness and Outcomes Research Program in Oncology at the Duke Cancer Institute since 2007.
Fred Hutchinson Cancer Research Center Promotes Frederick Appelbaum as Seattle Organization's Executive Vice President and Deputy Director
Sep 17 13
After more than three decades of researching blood cancers at the Fred Hutchinson Cancer Research Center, Dr. Frederick Appelbaum is stepping into a new and more public role as the Seattle organization's executive vice president and deputy director. Appelbaum is being promoted from his position as senior vice president and director of the Clinical Research Division at the Hutchinson Center, which he held for 20 years. In his new role, Appelbaum will have more responsibility for the organization's finances, including raising money through philanthropy and federal grants. He will still be able to conduct research, and he will lead the institution's efforts to establish research partnerships with the National Cancer Institute and other federal agencies. Appelbaum will also be a public face for the Hutch, sharing the organization's clinical research with the medical community.
Fred Hutchinson Cancer Research Center Announces Board Changes
Jun 21 13
Former Washington Gov. Chris Gregoire has been appointed to Fred Hutchinson Cancer Research Center's board of trustees -- her first foray back into the public spotlight since completing her second gubernatorial term in January. She is among four new Fred Hutch board members appointed on June 21, 2013 for fiscal year 2013-2014, which brings the total number of those serving in this volunteer capacity from 16 to 20. Their terms will begin July 1, 2013. The other new board members are former telecommunications executive Theresa "Terry" Gillespie, information technology venture capitalist Matt McIlwain and Norman Metcalfe, a real estate financier and investor. Theresa "Terry" Gillespie is a managing director of Trilogy Partnership, spent more than a decade at Western Wireless Corp., where she held positions ranging from chief financial officer to vice chairman and director. Matt McIlwain is managing director of the Madrona Venture Group in Seattle. His close ties to those firms, combined with his passion for innovation, give him a unique perspective on how Fred Hutch can create a stronger alliance with the local technology sector. Norman Metcalfe has an extensive history and background in finance and investments. He is director of The Ryland Group, a nationwide homebuilder; and the Tejon Ranch Company, a diversified real estate development and agribusiness company in Southern California. Previously he was vice chairman and chief financial officer of the Irvine Company. In addition to its new members, the board of trustees has appointed new leadership: Paula Reynolds is a former vice chair of the board, has been appointed chair. Reynolds is former chair and CEO of Safeco and currently is president and CEO of PreferWest, a business advisory group. She succeeds Douglas Walker, former CEO and chairman of software company WRQ, as board chair. Jim Sinegal, co-founder and former CEO of Costco, an international retail chain, has been appointed vice chair. He is also a member of the board's executive committee. The Hutch's lifesaving mission inspires him to serve on the board. Former board chair Steve Davis, CEO of PATH, is also stepping down on June 21, 2013 after more than eight years of board service.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|